AI assistant
Sending…
Immunovant, Inc. — Director's Dealing 2019
Dec 20, 2019
31436_dirs_2019-12-20_0f2f094a-2264-4451-b15f-51ed6a8984c3.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Immunovant, Inc. (IMVT)
CIK: 0001764013
Period of Report: 2019-12-18
Reporting Person: Butchko Julia G. (Chief Dev. & Tech. Officer)
More from Immunovant, Inc.
Annual Report
2026
May 20
Regulatory Filings
2026
May 20
Director's Dealing
2026
Mar 20
Director's Dealing
2026
Feb 27
Earnings Release
2026
Feb 6
Interim / Quarterly Report
2026
Feb 6
Director's Dealing
2026
Jan 23
Director's Dealing
2026
Jan 9
Director's Dealing
2025
Dec 19
Capital/Financing Update
2025
Dec 12